Emergent Biosolutions (EBS) Files $180M Mixed Shelf; 3M Common for Shareholders
Get Alerts EBS Hot Sheet
Join SI Premium – FREE
Emergent Biosolutions, Inc. (NYSE: EBS) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $180 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Emergent also filed to sell up to 3 million of its Common on behalf of selling shareholders. Emergent will not receive proceeds from the secondary offering.
Emergent also filed to sell up to 3 million of its Common on behalf of selling shareholders. Emergent will not receive proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canoo Inc. (GOEV) Provides Update on $62M Share Pre-Paid Advance Agreement
- Cadre Holdings (CDRE) Prices Share Offerings at $35/sh
- Madrigal Pharma (MDGL) Announces Pricing of Upsized $600 Million Public Offering
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!